Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasumasa Nishimura

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
International Journal of Clinical Oncology|December 24, 2004
Rationale for chemoradiotherapyYasumasa Nishimura
International Journal of Clinical Oncology|June 15, 2016
Biological imaging in clinical oncology-introductionYasumasa Nishimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 18, 2015
[Intensity modulated radiation therapy]Yasumasa Nishimura
International Journal of Clinical Oncology|April 9, 2020
A message from the new editor-in-chiefYasumasa Nishimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 20, 2011
[IMRT for esophageal neoplasms]Yasumasa Nishimura, Ryuta Koike
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 26, 2014
[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 2. The role of radiation therapy for lung cancer]Kiyoshi Nakamatsu, Yasumasa Nishimura
International Journal of Clinical Oncology|April 3, 2019
Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a reviewHiroshi Doi, Kiyoshi Nakamatsu, Yasumasa Nishimura
World Journal of Oncology|August 28, 2020
Effect of Rapamycin on the Radio-Sensitivity of Cultured Tumor Cells Following Boron Neutron Capture ReactionHitoshi Tatebe, Shin-Ichiro Masunaga, Yasumasa Nishimura
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancerMasayuki Takeda, Isamu Okamoto, Yasumasa Nishimura, et al.
Radiation Protection Dosimetry|March 25, 2017
MEASUREMENT OF ABSORPTION DOSE OUTSIDE IRRADIATION FIELD IN IMRTMakoto Hirata, Hajime Monzen, Kohei Hanaoka, et al.
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
International Journal of Clinical Oncology|December 24, 2004
Rationale for chemoradiotherapyYasumasa Nishimura
International Journal of Clinical Oncology|June 15, 2016
Biological imaging in clinical oncology-introductionYasumasa Nishimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 18, 2015
[Intensity modulated radiation therapy]Yasumasa Nishimura
International Journal of Clinical Oncology|April 9, 2020
A message from the new editor-in-chiefYasumasa Nishimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 20, 2011
[IMRT for esophageal neoplasms]Yasumasa Nishimura, Ryuta Koike
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 26, 2014
[Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 2. The role of radiation therapy for lung cancer]Kiyoshi Nakamatsu, Yasumasa Nishimura
International Journal of Clinical Oncology|April 3, 2019
Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a reviewHiroshi Doi, Kiyoshi Nakamatsu, Yasumasa Nishimura
World Journal of Oncology|August 28, 2020
Effect of Rapamycin on the Radio-Sensitivity of Cultured Tumor Cells Following Boron Neutron Capture ReactionHitoshi Tatebe, Shin-Ichiro Masunaga, Yasumasa Nishimura
Lung Cancer (Auckland, N.Z.)|February 18, 2017
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancerMasayuki Takeda, Isamu Okamoto, Yasumasa Nishimura, et al.
Radiation Protection Dosimetry|March 25, 2017
MEASUREMENT OF ABSORPTION DOSE OUTSIDE IRRADIATION FIELD IN IMRTMakoto Hirata, Hajime Monzen, Kohei Hanaoka, et al.
Pageof 20